Citalopram Hydrobromide

DRUG8 trials

Sponsors

Boston University, Alliance for Clinical Trials in Oncology, Mayo Clinic, University of Pittsburgh, Torrent Pharmaceuticals Limited

Conditions

AnxietyAutistic DisorderBreast CancerDepressionHealthyHot FlashesPsychosocial Effects of Cancer and Its Treatment

Phase 1

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

CompletedNCT00940238

Torrent Pharmaceuticals LimitedHealthy

Updated: 2017-10-24

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

CompletedNCT00939835

Torrent Pharmaceuticals LimitedHealthy

Updated: 2017-10-24

Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

CompletedNCT01149980

Dr. Reddy's Laboratories LimitedHealthy

Start: 2003-10-31End: 2003-11-30Updated: 2010-06-24

Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

CompletedNCT01149967

Dr. Reddy's Laboratories LimitedHealthy

Start: 2003-10-31End: 2003-11-30Updated: 2010-06-24

Phase 2

Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)

CompletedNCT00086645

Boston UniversityAutistic Disorder

Start: 2004-04-30End: 2007-04-30Updated: 2017-03-10

Phase 3

Citalopram in Treating Postmenopausal Women With Hot Flashes

CompletedNCT00363909

Alliance for Clinical Trials in OncologyBreast Cancer, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment

Start: 2006-11-30End: 2010-12-31Updated: 2016-12-13

Unknown Phase

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

CompletedNCT00667121

Mayo ClinicBreast Cancer, Depression, Hot Flashes +1

Start: 2011-03-16End: 2014-05-27Updated: 2025-02-14

Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety

CompletedNCT00930293

University of PittsburghAnxiety, Depression

Start: 2009-07-31End: 2012-06-30Updated: 2016-02-09

Related Papers

Baseline Factors Predicting Placebo Response to Treatment in Children and Adolescents With Autism Spectrum Disorders

JAMA Pediatrics2013-09-2466 citations

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

2009-06-01286 citations